Your browser doesn't support javascript.
loading
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.
Sperr, Wolfgang R; Herndlhofer, Susanne; Gleixner, Karoline; Girschikofsky, Michael; Weltermann, Ansgar; Machherndl-Spandl, Sigrid; Sliwa, Thamer; Poehnl, Rainer; Buxhofer-Ausch, Veronika; Strecker, Karin; Hoermann, Gregor; Knoebl, Paul; Jaeger, Ulrich; Geissler, Klaus; Kundi, Michael; Valent, Peter.
Afiliación
  • Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Herndlhofer S; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Wien, Austria.
  • Gleixner K; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Girschikofsky M; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Weltermann A; 1st Medical Department, Hospital of the Elisabethinen Linz, Linz, Austria.
  • Machherndl-Spandl S; 1st Medical Department, Hospital of the Elisabethinen Linz, Linz, Austria.
  • Sliwa T; 1st Medical Department, Hospital of the Elisabethinen Linz, Linz, Austria.
  • Poehnl R; 5th Medical Department, Krankenhaus Hietzing, Wien, Austria.
  • Buxhofer-Ausch V; 3rd Medical Department, Kaiser-Franz-Josef-Spital, Wien, Austria.
  • Strecker K; 1st Medical Department, Hospital of the Elisabethinen Linz, Linz, Austria.
  • Hoermann G; 2nd Medical Department, Donauspital, Wien, Austria.
  • Knoebl P; 2nd Medical Department, Donauspital, Wien, Austria.
  • Jaeger U; Department of Laboratory Medicine, Medical University of Vienna, Wien, Austria.
  • Geissler K; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Kundi M; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Valent P; 5th Medical Department, Krankenhaus Hietzing, Wien, Austria.
Am J Hematol ; 92(10): E567-E574, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28699225
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vidarabina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Citarabina / Quimioterapia de Consolidación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vidarabina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Citarabina / Quimioterapia de Consolidación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Austria